ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 130 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $35,000 | -16.7% | 24,071 | -17.9% | 0.00% | – |
| Q4 2016 | $42,000 | -19.2% | 29,324 | -1.7% | 0.00% | – |
| Q3 2016 | $52,000 | -5.5% | 29,824 | -7.7% | 0.00% | – |
| Q2 2016 | $55,000 | -14.1% | 32,324 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $64,000 | +166.7% | 32,324 | +162.3% | 0.00% | – |
| Q3 2015 | $24,000 | -62.5% | 12,324 | -10.2% | 0.00% | -100.0% |
| Q2 2015 | $64,000 | +6.7% | 13,724 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $60,000 | -23.1% | 13,724 | -38.8% | 0.00% | 0.0% |
| Q4 2014 | $78,000 | -14.3% | 22,424 | +3.4% | 0.00% | 0.0% |
| Q3 2014 | $91,000 | -24.8% | 21,685 | +5.3% | 0.00% | 0.0% |
| Q2 2014 | $121,000 | -7.6% | 20,585 | -1.0% | 0.00% | -50.0% |
| Q1 2014 | $131,000 | +22.4% | 20,785 | +13.7% | 0.00% | 0.0% |
| Q4 2013 | $107,000 | -14.4% | 18,285 | -23.0% | 0.00% | 0.0% |
| Q3 2013 | $125,000 | -23.8% | 23,760 | +11.6% | 0.00% | -33.3% |
| Q2 2013 | $164,000 | – | 21,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |